Medicine dropper tube and method for manufacturing same
The integral formation of the drop-type medicine tube with obliquely extending insertion portions and UHMWPE material addresses processing difficulties and space utilization issues, providing a convenient and durable solution for dispensing eye drops by simplifying the manufacturing process and enhancing dispensing accuracy.
Patent Information
- Application Number
- PCT/KR2024/006332
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-18
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-21
AI Technical Summary
Conventional drop-type medicine tubes face challenges with processing difficulty, low space utilization efficiency, and inconvenience in accurately dispensing eye drops due to narrow discharge sections and separate molding of body and cover parts, leading to defective products and increased complexity in manufacturing.
The drop-type medicine tube is designed with a main body and cover part formed integrally through injection molding, featuring a medicine receiving portion with obliquely extending insertion portions and a medicine discharge part that increases in diameter, allowing for easier injection and discharge of medicine, and made from ultra-high molecular weight polyethylene for enhanced durability and resistance.
This design simplifies the manufacturing process, improves space utilization, and enhances user convenience by reducing defects and facilitating accurate dispensing of eye drops, while the use of UHMWPE ensures durability and resistance to chemical degradation.
Smart Images

Figure KR2024006332_21112024_PF_FP_ABST
Abstract
Description
Drip-type drug tube and method for manufacturing the same
[0001] The present invention relates to a drip-type medicine tube and a method for manufacturing the same.
[0002] The recent increase in visual media such as computers, tablets, and TVs, the rise of mobile content, and the worsening atmospheric environment have increased the burden on the eyes. Furthermore, the growing emphasis on external aesthetics has led to a rise in the use of contact lenses, which directly irritate the cornea, rather than glasses, which do not. Consequently, the use of eye drops, such as artificial tears and eye drops, is on the rise.
[0003] As the use of eye drops, such as artificial tears and eye drops, increases, research is actively underway on containers that can store and use these drops easily. Specifically, research is actively underway on eye drop tubes, and their applications are expanding beyond eye drops to include storing and using other reagents.
[0004] Fig. 1 is a drawing showing a conventional drip-type medicine tube. Referring to Fig. 1, a conventional drip-type medicine tube (T') forms an exterior and may include a main body (1') that contains a medicine and a cover part (3') that is connected to the main body (1').
[0005] The main body (1') may include a drug receiving portion (11') in which an internal space is formed to receive a drug, and the drug receiving portion (11') may include a drug discharge portion (111') through which the drug is discharged when the cover portion (3') is removed.
[0006] Specifically, a conventional drip-type medicine tube (T') can have a main body (1') produced by injection molding, and a cover part (3') formed by injection molding separately from the main body (1'). After the main body (1') and the cover part (3') are each injection molded, eye drops can be injected through the medicine discharge part (111') of the main body (1').
[0007] However, the medicine discharge unit (111') has a narrow discharge cross-sectional area so that a small amount of eye drops is discharged when the user uses it later, making it inconvenient to accurately place the medicine injection device in the medicine discharge unit (111') and inject the exact amount, and many defective products were generated during the process.
[0008] In particular, when multiple drop-type medicine tubes (T') are placed and eye drops are injected into multiple drop-type medicine tubes (T') simultaneously through a medicine injection device, the difficulty of the process increases and a problem occurs in which a large number of defective products are generated.
[0009] In addition, a process of joining the main body (1') and the cover part (3') to supply the final product to the user may be performed. That is, a process of injecting a chemical through the chemical discharge part (111') and then interlocking the chemical discharge part (111') and the cover part (3') and joining them may be performed.
[0010] In the process of joining the medicine discharge unit (111') and the cover unit (3'), the end of the medicine discharge unit (111') and the cover unit (3') are joined, so the space (X') at the end of the medicine discharge unit (111') cannot be used to store eye drops, and thus a problem of reduced space utilization efficiency also occurred.
[0011] Accordingly, research is actively being conducted on the structural design and manufacturing method of drop-type drug tubes with simplified manufacturing processes and reduced process difficulty.
[0012] Embodiments of the present invention aim to provide a drop-type medicine tube having a structure with low process difficulty.
[0013] In addition, embodiments of the present invention seek to provide a drop-type drug tube with maximized space utilization efficiency.
[0014] In addition, embodiments of the present invention aim to provide a drip-type medicine tube having a structure that can be conveniently used by a user.
[0015] In addition, the present invention aims to provide a method for manufacturing a drop-type medicine tube capable of manufacturing the drop-type medicine tubes of the above-described embodiments.
[0016] According to the present embodiments, the drip-type medicine tube has a main body and a cover formed integrally, a medicine is injected into the main body, and the main body can be bonded.
[0017] Specifically, it may include a main body part that forms an appearance and accommodates a drug, and a cover part that is formed integrally with the main body part and is provided to be removed when the drug is used, wherein the main body part may include a drug receiving part having an internal space formed to accommodate the drug, a main body support part that extends to the outside of the drug receiving part, an upper insertion part that extends upwardly and obliquely away from the cover part from the drug receiving part and the main body support part, and a lower insertion part that faces the upper insertion part and extends downwardly and obliquely away from the cover part from the drug receiving part and the main body support part.
[0018] The internal space is formed by injection molding with a mold inserted between the upper insertion part and the lower insertion part, and after the mold is removed, the drug is injected into the internal space, and the upper insertion part and the lower insertion part can be joined.
[0019] Additionally, the angle (θ) formed by the upper insertion portion and the lower insertion portion may be set to 10 to 20 degrees.
[0020] Additionally, the angle (θ) formed by the upper insertion portion and the lower insertion portion may be set to 12.5 degrees to 17.5 degrees.
[0021] In addition, the drug receiving portion may be formed integrally with the cover portion and may include a drug discharge portion through which the drug is discharged when the cover portion is removed, a drug connection portion that extends away from the drug discharge portion to the cover portion and has an increasing diameter, a drug receiving main body portion that extends away from the drug connection portion to the cover portion and has a constant diameter, and a drug finishing portion that extends away from the drug receiving main body to the cover portion and has a decreasing diameter.
[0022] The upper insertion portion is formed by passing through the drug finishing portion at a first point of the drug receiving main body, and the lower insertion portion is formed by passing through the drug finishing portion at a first point of the drug receiving main body, and the first point may be positioned closer to the drug finishing portion than the center of the drug receiving main body.
[0023] In addition, the distance (E1) from the drug finishing part to the first point may be provided to be between 0.7 and 0.9 of the distance (E2) from the drug finishing part to the center of the drug receiving body part.
[0024] In addition, the distance (E1) from the drug finishing part to the first point may be provided to be between 0.75 and 0.85 of the distance (E2) from the drug finishing part to the center of the drug receiving body part.
[0025] In addition, the thickness (t1) of the above-mentioned drug connection part may be provided to be greater than the thickness (t2) of the above-mentioned drug receiving body part and the thickness (t3) of the above-mentioned drug finishing part.
[0026] In addition, the thickness (t2) of the drug-receiving body and the thickness (t3) of the drug-finishing body are provided to be the same, and the thickness (t1) of the drug-connecting body may be provided to be 2 to 4 times the thickness (t2) of the drug-receiving body.
[0027] In addition, the main body part may further include an insertion support part including a first insertion support part protruding upward from a terminal end of the upper insertion part and a second insertion support part protruding downward from a terminal end of the lower insertion part.
[0028] In addition, the cover part may be provided in a plate shape and may include a cover body part spaced apart from the body support part, a cover protrusion part formed to protrude in a shape corresponding to the drug discharge part on one surface of the cover body part facing the drug discharge part, and a cover removal part that extends from the cover body part to both ends of the body support part and is provided so that the cross-sectional area decreases as it moves from the cover body part toward the body support part.
[0029] The above cover protrusion may include a cover protrusion main body part having an inner diameter larger than an outer diameter of the drug discharge part, and a cover protrusion central part formed by being recessed in a direction away from the drug discharge part on one side of the cover protrusion main body part facing the drug discharge part.
[0030] In addition, the outer diameter (D1) of the cover protrusion body part may be provided as 1.1 to 1.3 times the outer diameter (D2) of the drug discharge part.
[0031] In addition, the manufacturing method for manufacturing the above-described drip-type medicine tube may include a placement step of arranging a first mold for integrally forming the exterior of the main body and the cover and a second mold for forming the internal space of the medicine receiving portion, an injection step of injecting a molding material between the first mold and the second mold, a removal step of removing the second mold between the upper insertion portion and the lower insertion portion, an injection step of injecting the medicine between the upper insertion portion and the lower insertion portion, and a joining step of joining the upper insertion portion and the lower insertion portion.
[0032] Meanwhile, a drip-type medicine tube according to another embodiment of the present invention forms an exterior and includes a main body portion for containing a medicine and a cover portion formed integrally with the main body portion and provided to be removed when the medicine is used, wherein the main body portion includes a medicine containing portion having an internal space for containing the medicine, a main body support portion extended to the outside of the medicine containing portion, and a mold insert portion provided at an end of the medicine containing portion and into which a mold is inserted, and the internal space is formed by injection molding with the mold inserted into the mold insert portion, and after the mold is removed, the medicine is injected into the internal space, and the mold insert portion can be joined.
[0033] In addition, the drug receiving portion is formed integrally with the cover portion, and includes a drug discharge portion through which the drug is discharged when the cover portion is removed, a drug connection portion that extends away from the drug discharge portion to the cover portion and has an increasing diameter, a drug receiving main body portion that extends away from the drug connection portion to the cover portion and has a constant diameter, and a drug finishing portion that extends away from the drug receiving main body portion to the cover portion and has a decreasing diameter, and the drug finishing portion can be formed by joining the mold insert portion.
[0034] In addition, the body finishing part is connected to the drug finishing part and the body support part, and further includes a body finishing part having a diameter smaller than the drug finishing part, and the body finishing part can be formed by joining the mold insertion part.
[0035] In addition, the thickness (t1) of the drug connection part is provided to be greater than the thickness (t2) of the drug receiving body part and the thickness (t3) of the drug finishing part, the thickness (t2) of the drug receiving body part is provided to be greater than the thickness (t3) of the drug finishing part, and the thickness (t1) of the drug connection part may be provided to be 2 to 4 times the thickness (t2) of the drug receiving body part.
[0036] In addition, the cover part is provided in a plate shape, and includes a cover main body part spaced apart from the main body support part, a cover protrusion part formed to protrude in a shape corresponding to the medicine discharge part on one surface of the cover main body part facing the medicine discharge part, and a cover removal part that extends from the cover main body part to both ends of the main body support part and is provided so that the cross-sectional area decreases as it moves from the cover main body part toward the main body support part, and the cover protrusion part may include a cover protrusion main body part having an inner diameter larger than an outer diameter of the medicine discharge part, and a cover protrusion closing part that is provided on one surface of the cover protrusion main body part facing the medicine discharge part and extends in parallel with the medicine discharge part.
[0037] Additionally, the main body and the cover may be made of a material containing 50% ultra-high molecular weight polyethylene (UHMWPE).
[0038] Embodiments of the present invention can provide a drop-type medicine tube having a structure with low process difficulty.
[0039] In addition, embodiments of the present invention can provide a drop-type medicine tube with maximized space utilization efficiency.
[0040] In addition, embodiments of the present invention can provide a drip-type medicine tube having a structure that can be conveniently used by a user.
[0041] In addition, a method for manufacturing a drop-type medicine tube capable of manufacturing the drop-type medicine tubes of the above-described embodiments can be provided.
[0042] Figure 1 is a drawing showing a conventional drip-type medicine tube.
[0043] Figure 2 is a perspective view of a drip-type medicine tube according to one embodiment of the present invention.
[0044] FIG. 3 is a drawing showing the manufacture of a drip-type medicine tube according to one embodiment of the present invention.
[0045] FIG. 4 is a drawing showing an upper insertion part and a lower insertion part according to one embodiment of the present invention.
[0046] Figure 5 is a cross-sectional view of a drip-type drug tube according to one embodiment of the present invention.
[0047] Figure 6 is a cross-sectional view of a main body according to one embodiment of the present invention.
[0048] Fig. 7 is a drawing showing a connection structure of a main body and a cover according to one embodiment of the present invention.
[0049] Figure 8 is a flowchart showing a method for manufacturing a drip-type medicine tube according to one embodiment of the present invention.
[0050] Figure 9 is a perspective view of a drip-type medicine tube according to another embodiment of the present invention.
[0051] FIG. 10 is a drawing showing the manufacture of a drip-type medicine tube according to another embodiment of the present invention.
[0052] Fig. 11 is a perspective view of a drip-type drug tube according to another embodiment of the present invention, showing a state before the bonding step.
[0053] Fig. 12 is a cross-sectional view of a drip-type drug tube according to another embodiment of the present invention.
[0054] Fig. 13 is a drawing showing a method for manufacturing a drip-type medicine tube according to another embodiment of the present invention.
[0055] Below, with reference to the attached drawings, an embodiment of the present invention is described in detail so that a person having ordinary skill in the art to which the present invention pertains can easily practice it.
[0056] However, the present invention can be implemented in various different forms and is not limited to the embodiments described herein. In order to clearly explain the present invention in the drawings, parts irrelevant to the description have been omitted, and similar parts have been designated with similar reference numerals throughout the specification.
[0057] In this specification, duplicate descriptions of identical components are omitted.
[0058] Additionally, when a component is referred to herein as being "connected" or "connected" to another component, it should be understood that while it may be directly connected or connected to that other component, there may be other components present in between. Conversely, when a component is referred to herein as being "directly connected" or "directly connected" to another component, it should be understood that there are no other components present in between.
[0059] Additionally, the terms used herein are only used to describe specific embodiments and are not intended to limit the present invention.
[0060] Also, in this specification, singular expressions may include plural expressions unless the context clearly indicates otherwise.
[0061] In addition, in this specification, it should be understood that terms such as “include” or “have” are intended to specify only the presence of a feature, number, step, operation, component, part, or combination thereof described in the specification, and do not exclude in advance the possibility of the presence or addition of one or more other features, numbers, steps, operations, components, parts, or combinations thereof.
[0062] Also, in this specification, the term 'and / or' includes a combination of multiple listed items or any item among multiple listed items. In this specification, 'A or B' can include 'A', 'B', or 'both A and B'.
[0063] Fig. 2 is a perspective view of a drip-type medicine tube according to one embodiment of the present invention. Fig. 3 is a drawing showing the manufacturing of a drip-type medicine tube according to one embodiment of the present invention. Referring to Figs. 2 and 3, a drip-type medicine tube (T) according to one embodiment of the present invention may include a main body portion (1) and a cover portion (3).
[0064] The main body (1) forms an exterior and can accommodate a chemical, and the cover (3) is formed integrally with the main body (1) and can be provided to be removed when the chemical is used. That is, the cover (3) is formed integrally with the main body (1) when the product is shipped so that the chemical is not discharged to the outside, and the user can remove it when using the product to use the chemical in the main body (1).
[0065] The above-mentioned medicines can generally be eye drops such as artificial tears or eye drops, or can refer to liquid reagents, etc.
[0066] In addition, the cover part (3) can provide convenience by allowing the user to temporarily store and then use the medicine again by being inserted and combined with the main body part (1) when there is medicine remaining after using the medicine.
[0067] In addition, since the cover part (3) is formed integrally with the main body part (1) during injection molding, no separate bonding is required to combine the cover part (3) and the main body part (1), so the difficulty of the process can be reduced.
[0068] Specifically, the main body (1) may include a drug receiving portion (11), a main body support portion (13), an upper insertion portion (15), and a lower insertion portion (17). The drug receiving portion (11) may have an internal space formed to accommodate a drug.
[0069] The main body support part (13) can be extended to the outside of the drug container part (11), and can improve durability and make it easy for the user to grip and use the product when producing the product, distributing the product, and using the product.
[0070] The upper insertion portion (15) can be extended upwardly and inclined away from the cover portion (3) in the drug receiving portion (11) and the main body support portion (13). The lower insertion portion (17) faces the upper insertion portion (15) and can be extended downwardly and inclined away from the cover portion (3) in the drug receiving portion (11) and the main body support portion (13).
[0071] The upper insertion part (15) and the lower insertion part (17) can be provided symmetrically along the center line of the drug receiving part (11), and the positions of the upper insertion part (15) and the lower insertion part (17) can change depending on the viewing direction.
[0072] An internal space (V) can be formed by injection molding with a mold (Y) inserted between the upper insertion part (15) and the lower insertion part (17). In addition, after the mold (Y) is removed, a chemical can be injected into the internal space (V), and the upper insertion part (15) and the lower insertion part (17) can be joined.
[0073] That is, unlike the conventional method, the drip-type medicine tube (T) according to one embodiment of the present invention has a main body (1) and a cover (3) integrally formed by injection molding, so that the process can be much simpler than separately injection molding the main body (1) and the cover (3) and then joining them.
[0074] In addition, the drip-type medicine tube (T) according to one embodiment of the present invention can solve the problem that it is difficult to accurately place the medicine injection device in the medicine discharge portion (111) having a small area and to inject a fixed amount by injecting the medicine through the upper insertion portion (15) and the lower insertion portion (17) as described below.
[0075] In addition, compared to the conventional method, the defect rate that occurs when multiple drip-type drug tubes (T) are aligned and injected simultaneously into a drug injection device can be visibly improved, thereby achieving the effects of process simplification, process accuracy improvement, and economic improvement.
[0076] In addition, the upper insertion part (15) extends upward, and the lower insertion part (17) extends downward, so that the mold (Y) for creating an internal space (V) during injection molding can move efficiently without interference, and the chemical injection device can move efficiently without interference between the upper insertion part (15) and the lower insertion part (17).
[0077] Furthermore, in the past, when welding the chemical discharge part (111) and the cover part (3), there were many possibilities of defects occurring due to the narrow welding area, but the drip-type chemical tube (T) according to one embodiment of the present invention can minimize defects by joining the upper insertion part (15) and the lower insertion part (17) with relatively large areas, and can also prevent deformation of the chemical due to heat or ultrasonic waves as much as possible by maximizing the distance from the chemical when joining.
[0078] Fig. 4 is a drawing showing an upper insertion part and a lower insertion part according to one embodiment of the present invention. Fig. 5 is a cross-sectional view of a drip-type medicine tube according to one embodiment of the present invention. Fig. 6 is a cross-sectional view of a main body according to one embodiment of the present invention.
[0079] Referring to FIGS. 4 to 6, the upper insertion portion (15) and the lower insertion portion (17) according to one embodiment of the present invention can form a predetermined angle. That is, the angle (θ) formed by the upper insertion portion (15) and the lower insertion portion (17) can be set to 10 to 20 degrees.
[0080] That is, the mold (Y) may include a first mold (Y1) forming the overall appearance and a second mold (Y2) forming the internal space (V), and a drop-type drug tube (T) may be manufactured by injection molding while the first mold (Y1) and the second mold (Y2) are arranged.
[0081] When the second mold (Y2) forming the internal space (V) after forming the drip-type drug tube (T) is removed, the upper insertion part (15) and the lower insertion part (17) can form an angle of 10 to 20 degrees so that the second mold (Y2) can be easily withdrawn.
[0082] In addition, the angle (θ) formed by the upper insertion part (15) and the lower insertion part (17) is set to 10 to 20 degrees, so that the drug can be prevented from flowing outward as much as possible when the drug is injected into the internal space (V).
[0083] Furthermore, the angle (θ) formed by the upper insertion part (15) and the lower insertion part (17) is set to 10 to 20 degrees, so that it is easy to join the upper insertion part (15) and the lower insertion part (17) in a contact state after drug injection.
[0084] Specifically, the angle (θ) formed by the upper insertion portion (15) and the lower insertion portion (17) can be set to 12.5 degrees to 17.5 degrees. Accordingly, when the second mold (Y2) forming the internal space (V) after forming the drip-type medicine tube (T) is removed, the second mold (Y2) can be more easily withdrawn.
[0085] In addition, the angle (θ) formed by the upper insertion part (15) and the lower insertion part (17) is set to 12.5 to 17.5 degrees, so that the drug can be more easily prevented from flowing outward when the drug is injected into the internal space (V).
[0086] More specifically, the angle (θ) formed by the upper insertion portion (15) and the lower insertion portion (17) may be set to 14.5 degrees to 15.5 degrees. Accordingly, when the second mold (Y2) forming the internal space (V) after forming the drip-type medicine tube (T) is removed, the second mold (Y2) can be more easily withdrawn.
[0087] In addition, the angle (θ) formed by the upper insertion part (15) and the lower insertion part (17) is set to 14.5 to 15.5 degrees, so that the drug can be more easily prevented from flowing outward when the drug is injected into the internal space (V).
[0088] Meanwhile, referring again to FIGS. 5 and 6, the drug receiving portion (11) according to one embodiment of the present invention may include a drug discharge portion (111), a drug connection portion (113), a drug receiving main body portion (115), and a drug closing portion (117).
[0089] The drug discharge unit (111) is formed integrally with the cover unit (3), and the drug can be discharged when the cover unit (3) is removed. That is, the drug discharge unit (111) is provided with a diameter smaller than that of the drug receiving main body unit (115) described later, so that the drug can be discharged evenly from the drug receiving main body unit (115).
[0090] The drug connection part (113) may be provided to extend away from the drug discharge part (111) and the cover part (3) and to have an increased diameter. That is, the drug connection part (113) may connect the drug discharge part (111) and the drug receiving body part (115).
[0091] In order to solve the problem of the drug not being properly discharged when the drug is discharged due to the diameter suddenly increasing when the drug is directly flowed from the drug receiving body part (115) to the drug discharging part (111), the drug connecting part (113) may be provided so that the diameter increases as it moves from the drug discharging part (111) to the drug receiving body part (115).
[0092] The drug receiving main body (115) extends away from the drug connection part (113) and the cover part (3) and may be provided with a constant diameter. That is, the drug receiving main body (115) has the largest diameter and the largest area among the drug receiving parts (11), so that the drug can be effectively stored.
[0093] The drug closing portion (117) may be provided to extend away from the cover portion (3) in the drug receiving body portion (115) and to have a reduced diameter. That is, the drug closing portion (117) may be provided to have a reduced diameter in the drug receiving body portion (115) to facilitate contact and joining between the upper insertion portion (15) and the lower insertion portion (17).
[0094] That is, the drug receiving portion (11) can efficiently store drugs by diversifying the diameters of the drug discharge portion (111), drug connection portion (113), drug receiving main body portion (115), and drug closing portion (117), and can enable users to use the drug easily, and can also facilitate the manufacture of the product.
[0095] Meanwhile, the upper insertion part (15) is formed by passing through the drug finishing part (117) at the first point (U) of the drug receiving body part (115), and the lower insertion part (17) can be formed by passing through the drug finishing part (117) at the first point (U) of the drug receiving body part (115).
[0096] That is, the upper insertion part (15) and the lower insertion part (17) can be provided symmetrically with respect to the center line of the drug receiving body part (115), and can be formed by passing through the entire drug finishing part (117) on one side of the drug receiving body part (115).
[0097] Accordingly, when the second mold (Y2) forming the internal space (V) after forming the drip-type drug tube (T) is removed, the second mold (Y2) can be more easily withdrawn, and when the drug is injected, the drug can be easily prevented from flowing outward.
[0098] In addition, when the first mold (Y1) and the second mold (Y2) are removed after forming the drip-type drug tube (T), the appearance of the entire drip-type drug tube (T) is effectively maintained, thereby minimizing the defect rate.
[0099] Specifically, the distance (E1) from the drug finishing part (117) to the first point (U) may be set to be between 0.7 and 0.9 of the distance (E2) from the drug finishing part (117) to the center of the drug receiving body part (115).
[0100] Accordingly, when the second mold (Y2) forming the internal space (V) after forming the drip-type drug tube (T) is removed, the second mold (Y2) can be more easily withdrawn, and when the drug is injected, the drug can be more easily prevented from flowing outward.
[0101] In addition, when the first mold (Y1) and the second mold (Y2) are removed after forming the drip-type drug tube (T), the appearance of the entire drip-type drug tube (T) is effectively maintained, thereby further minimizing the defect rate.
[0102] More specifically, the distance (E1) from the drug finishing part (117) to the first point (U) may be set to be between 0.75 and 0.85 of the distance (E2) from the drug finishing part (117) to the center of the drug receiving body part (115).
[0103] Accordingly, when the second mold (Y2) forming the internal space (V) after forming the drip-type drug tube (T) is removed, the second mold (Y2) can be more easily withdrawn, and when the drug is injected, the drug can be more easily prevented from flowing outward.
[0104] In addition, when the first mold (Y1) and the second mold (Y2) are removed after forming the drip-type drug tube (T), the appearance of the entire drip-type drug tube (T) is effectively maintained, thereby further minimizing the defect rate.
[0105] Meanwhile, the thickness (t1) of the drug connection part (113) may be provided to be greater than the thickness (t2) of the drug receiving body part (115) and the thickness (t3) of the drug finishing part (117). That is, the drug connection part (113) connects the drug receiving body part (115) and the drug discharge part (111), and as a flow path through which the drug is discharged when the user uses the drug, the thickness is provided to be relatively large, thereby improving structural safety.
[0106] Specifically, the thickness (t2) of the drug receiving body (115) and the thickness (t3) of the drug finishing body (117) are provided to be the same, and the thickness (t1) of the drug connecting body (113) can be provided to be 2 to 4 times the thickness (t2) of the drug receiving body (115).
[0107] Since the drug receiving body (115) and the drug closing part (117) are not the paths through which the drug is discharged when the user uses the drug, they are provided with a relatively small thickness to store the drug as much as possible, thereby maximizing the storage capacity while ensuring a certain level of structural safety.
[0108] The thickness (t1) of the drug connection part (113) is set to 2 to 4 times the thickness (t2) of the drug receiving body part (115), so that the structural safety can be more efficiently secured when the user uses the drug, and the overall storage capacity and the user's usability can be effectively secured.
[0109] Meanwhile, the main body (1) according to one embodiment of the present invention may include an insertion support portion (19). The insertion support portion (19) may include a first insertion support portion (191) and a second insertion support portion (193). The first insertion support portion (191) may protrude upward from the end of the upper insertion portion (15), and the second insertion support portion (193) may protrude downward from the end of the lower insertion portion (17).
[0110] In addition, the first insertion support part (191) may be provided at the center of the upper insertion part (15), the second insertion support part (193) may be provided at the center of the lower insertion part (17), and the first insertion support part (191) and the second insertion support part (193) may be provided symmetrically.
[0111] The first insertion support part (191) and the second insertion support part (193) can increase the structural rigidity of the contactable portion of the upper insertion part (15) and the lower insertion part (17) when the second mold (Y2) moves between the upper insertion part (15) and the lower insertion part (17), thereby preventing tearing or breakage as much as possible.
[0112] In addition, the first insertion support part (191) is provided in a central part of the upper insertion part (15) rather than the entire end, and the second insertion support part (193) is provided in a central part of the lower insertion part (17) rather than the entire end, thereby effectively securing structural safety while minimizing the increase in the weight or volume of the entire drip-type medicine tube (T).
[0113] Fig. 7 is a drawing showing the connection structure of the main body and the cover part according to one embodiment of the present invention. Referring to Figs. 5 to 7, the cover part (3) according to one embodiment of the present invention may include a cover main body part (31), a cover protrusion part (33), and a cover removal part (35).
[0114] The cover main body (31) is provided in a plate shape and can be spaced apart from the main body support part (13). That is, the cover main body (31) can be provided in a plate shape so that the user can easily grip it when removing the cover part (3), and the main body support part (13) can also be provided in a plate shape so that the user can easily grip it and remove the cover part (3).
[0115] In addition, the thickness of the cover main body (31) may be provided to be greater than the thickness of the main body support part (13). That is, the main body support part (13) is connected to the drug receiving part (11) where the drug is received, so that a certain level of structural safety can be secured, but the cover main body part (31) occupies most of the area of the cover part (3), so that the user can easily grip it when removing it, and the thickness may be provided to be greater than the main body support part (13) so that the structural safety is increased.
[0116] Specifically, the thickness of the cover main body (31) can be set to 1.1 to 1.3 times the thickness of the main body support part (13). That is, the thickness of the cover main body (31) is set to 1.1 to 1.3 times the thickness of the main body support part (13), so that the user can easily remove it and effectively secure structural safety.
[0117] More specifically, the thickness of the cover main body (31) may be set to 1.15 to 1.25 times the thickness of the main body support part (13). That is, the thickness of the cover main body (31) may be set to 1.15 to 1.35 times the thickness of the main body support part (13), so that the user can more easily remove it and more effectively secure structural safety.
[0118] The cover protrusion (33) may be formed to protrude in a shape corresponding to the drug discharge portion (111) on one side of the cover main body (31) facing the drug discharge portion (111). That is, the cover protrusion (33) may be formed to have the same shape as the drug discharge portion (111) and a larger cross-section than the drug discharge portion (111).
[0119] Accordingly, the user can effectively remove the cover part (3) and, after using the medicine, close the medicine discharge part (111) again through the cover protrusion part (33) to enable temporary storage.
[0120] The cover removal part (35) extends from the cover main body part (31) to both ends of the main body support part (13), and may be provided so that the cross-sectional area decreases as it moves from the cover main body part (31) toward the main body support part (13). That is, the cover removal part (35) is a part that is directly connected to the main body part (1), and the cover main body part (31) is provided with a thickness greater than a certain level to ensure structural safety while allowing the user to easily remove the cover part (3) from the main body part (1).
[0121] Specifically, the cover removal portion (35) can be extended from the top and bottom of the cover main body portion (31) toward the center of the main body support portion (13) so that the cross-sectional area decreases. Accordingly, a user can easily remove the cover portion (3) from the main body portion (1).
[0122] The cover protrusion (33) may include a cover protrusion main body (331) and a cover protrusion central body (333). The cover protrusion main body (331) may have an inner diameter larger than the outer diameter of the chemical discharge unit (111). That is, the cover protrusion main body (331) is provided so that the inner circumference only contacts the outer circumference of the chemical discharge unit (111), so that the user can easily detach it when removing it.
[0123] In addition, after the user uses the drip-type medicine tube (T), the cover protrusion body part (331) is inserted to surround the outer surface of the medicine discharge part (111), so that the medicine can be temporarily stored effectively.
[0124] The cover protrusion central portion (333) can be formed by being recessed in a direction away from the drug discharge portion (111) on one side of the cover protrusion main body portion (331) facing the drug discharge portion (111). That is, the cover protrusion central portion (333) can store drugs together with the drug discharge portion (111) in the space formed by being recessed, thereby maximizing the capacity of the entire drip-type drug tube (T).
[0125] In addition, even if air enters the space between the upper insertion part (15) and the lower insertion part (17) when the medicine is injected and the internal space (V) is partially occupied by air, the medicine stored in the cover protrusion center part (333) can supplement this.
[0126] In addition, the cover protrusion central portion (333) can close the drug discharge portion (111) when the user inserts the drug tube (T) into the cover protrusion main body portion (331) to cover the outer surface of the drug discharge portion (111) to prevent the drug from leaking to the outside as much as possible.
[0127] In other words, unlike conventional methods, the drip-type medicine tube (T) according to one embodiment of the present invention does not have a joint between the cover protrusion (33) and the medicine discharge portion (111), so that the space of the medicine discharge portion (111) can be used to the maximum extent.
[0128] In addition, since there is no joint between the cover protrusion (33) and the drug discharge portion (111), the cover protrusion central portion (333) can be formed, so that the drug can be stored in the cover protrusion central portion (333) together with the drug discharge portion (111). In other words, the space utilization of the drip-type drug tube (T) through the cover protrusion central portion (333) can be maximized.
[0129] Meanwhile, the outer diameter (D1) of the cover protrusion body part (331) may be provided at 1.1 to 1.3 times the outer diameter (D2) of the drug discharge part (111). That is, the cover protrusion body part (331) may be provided at 1.1 to 1.3 times the outer diameter (D1) of the drug discharge part (111), thereby ensuring maximum structural safety during injection molding and the post-injection molding product manufacturing process, while minimizing the volume or weight of the product.
[0130] In addition, the cover protrusion body part (331) has an outer diameter (D1) of 1.1 to 1.3 times the outer diameter (D2) of the drug discharge part (111), so that the user can easily remove the cover part (3) when using the drug.
[0131] Specifically, the outer diameter (D1) of the cover protrusion body (331) may be set to 1.15 to 1.25 of the outer diameter (D2) of the drug discharge portion (111). Accordingly, structural safety can be secured as much as possible during the injection molding and post-injection molding product manufacturing process, while further minimizing the volume and weight of the product.
[0132] Additionally, it is possible to make it easier for the user to remove the cover (3) when using the medicine.
[0133] Figure 8 is a flowchart illustrating a method for manufacturing a drip-type medicine tube according to one embodiment of the present invention. The method (S) for manufacturing a drip-type medicine tube according to one embodiment of the present invention may include a placement step (S1), an injection step (S2), a removal step (S3), an injection step (S4), and a bonding step (S5).
[0134] That is, manufacturing the above-described drip-type drug tube (T) may include a placement step (S1), an injection step (S2), a removal step (S3), an injection step (S4), and a joining step (S5). The placement step (S1) may include placing a first mold (Y1) for integrally forming the exterior of the main body (1) and the cover part (3) and a second mold (Y2) for forming the internal space (V) of the drug receiving part (11).
[0135] The injection stage (S2) can inject a molding material between the first mold (Y1) and the second mold (Y2). In other words, the injection stage (S2) can be viewed as a type of injection molding that injection molds existing plastic injection products.
[0136] The removal step (S3) can remove the second mold (Y2) between the upper insertion part (15) and the lower insertion part (17). That is, the removal step (S3) can easily remove the second mold (Y2) due to the structural features of the upper insertion part (15) and the lower insertion part (17) described above.
[0137] In addition, the second mold (Y2) may be provided with an inner portion inserted into the inner space (V) having a smaller cross-sectional area than the outer portion for effective removal after injection molding. Accordingly, injection molding can be easily performed, removal after injection molding can be easily performed, and damage to the drip-type drug tube (T) can be minimized.
[0138] The injection step (S4) can inject the drug between the upper insertion part (15) and the lower insertion part (17). That is, the injection step (S4) can easily inject the drug due to the structural features of the upper insertion part (15) and the lower insertion part (17) described above.
[0139] The bonding step (S5) can bond the upper insertion part (15) and the lower insertion part (17). That is, the bonding step (S5) can perform bonding along the edges of the upper insertion part (15) and the lower insertion part (17) through heat welding or ultrasonic waves.
[0140] Accordingly, unlike the conventional method of welding between the chemical discharge unit (111) and the cover unit (3), the chemical discharge unit (111) and the cover unit (3) are formed as one, thereby maximizing the space between the chemical discharge unit (111) and the cover unit (3), thereby increasing space utilization.
[0141] In addition, unlike the conventional method of injecting chemicals through the chemical discharge section (111) and causing difficulties in positioning and quantitative injection of the chemical injection device, the chemical is injected between the upper insertion section (15) and the lower insertion section (17) which have a large surface area, making alignment and quantitative injection easy. In particular, it is more effective when injecting chemicals through multiple drop-type chemical tubes (T) at once.
[0142] Meanwhile, the drip-type medicine tube (T) according to one embodiment of the present invention may be made of a material containing 50% ultra-high molecular weight polyethylene (UHMWPE). That is, the main body (1) and the cover (3) may be made of a material containing 50% ultra-high molecular weight polyethylene (UHMWPE).
[0143] UHMWPE boasts excellent moisture resistance, abrasion resistance, resistance to various organic solvents, and resistance to strong acids and alkalis, making it a frequent replacement for steel (especially wire). Because it is much lighter than steel and floats, it is widely used in ship cables and fishing lines.
[0144] Steel cables, in particular, are extremely dangerous if they are severed under tension (a fatal blow to a person can result). However, UHMWPE cables are lightweight, so even if they are severed and sent flying, they won't cause serious injury. Furthermore, they are much cheaper and easier to manufacture than carbon fiber.
[0145] That is, the main body (1) and the cover (3) are made of a material containing 50% UHMWPE, so that the evaporation of the medicine inside the medicine tube can be prevented to the greatest extent possible even when stored for a long period of time.
[0146] Fig. 9 is a perspective view of a drip-type medicine tube according to another embodiment of the present invention. Fig. 10 is a drawing showing the manufacturing of a drip-type medicine tube according to another embodiment of the present invention. Referring to Figs. 9 and 10, a drip-type medicine tube (T) according to another embodiment of the present invention may include a main body portion (1) and a cover portion (3).
[0147] Any content that overlaps with the above will be omitted, and the explanation will focus on newly added components. However, the above-mentioned content should not be excluded from or interpreted as a limitation of the scope of the rights.
[0148] The main body (1) forms an exterior and can accommodate a drug, and the cover (3) is formed integrally with the main body (1) and can be provided to be removed when the drug is used. Specifically, the main body (1) can include a drug-accommodating portion (11), a main body support portion (13), and a mold insertion portion (18).
[0149] The drug receiving portion (11) may have an internal space formed to accommodate the drug. The main body support portion (13) may be extended to the outside of the drug receiving portion (11), thereby improving durability during product production, distribution, and use by the user, and enabling the user to easily grasp and use the product.
[0150] A mold insertion portion (18) is provided at the end of the drug receiving portion (11) so that a mold (Y) can be inserted. In addition, an internal space (V) is formed by injection molding while the mold is inserted into the mold insertion portion (18), and after the mold is removed, a drug is injected into the internal space (V), and the mold insertion portion (18) can be joined.
[0151] That is, the mold (Y) can be withdrawn through the mold insertion portion (18), and the drip-type drug tube (T) can be manufactured by joining the ends of the mold insertion portion (18). Specifically, the mold insertion portion (18) can be joined only in a direction perpendicular to the direction in which the drug receiving portion (11) moves away from the cover portion (3).
[0152] Accordingly, the mold insertion part (18) can minimize the bonding process when manufacturing a drip-type drug tube (T), thereby improving manufacturing efficiency. In addition, since only the lower end of the mold insertion part (18) is bonded, the bonding area is minimized, thereby minimizing the phenomenon of drug leakage.
[0153] Fig. 11 is a perspective view of a drip-type drug tube according to another embodiment of the present invention, showing the state before the bonding step (S5) is performed.
[0154] In the bonding step (S5), the upper and lower surfaces of the mold insertion part (18) are bonded through heat welding or ultrasonic welding, and the lower part of the bonding line (L) is bonded. Fig. 12 is a cross-sectional view of a drip-type drug tube according to another embodiment of the present invention. Referring to Fig. 12, the drug receiving part (11) according to another embodiment of the present invention may include a drug discharge part (111), a drug connection part (113), a drug receiving main body part (115), and a drug finishing part (117).
[0155] The drug discharge unit (111) is formed integrally with the cover unit (3), and the drug can be discharged when the cover unit (3) is removed. That is, the drug discharge unit (111) is provided with a diameter smaller than that of the drug receiving main body unit (115) described later, so that the drug can be discharged evenly from the drug receiving main body unit (115).
[0156] The drug connection part (113) may be provided to extend away from the drug discharge part (111) and the cover part (3) and to have an increased diameter. That is, the drug connection part (113) may connect the drug discharge part (111) and the drug receiving body part (115).
[0157] In order to solve the problem of the drug not being properly discharged when the drug is discharged due to the diameter suddenly increasing when the drug is directly flowed from the drug receiving body part (115) to the drug discharging part (111), the drug connecting part (113) may be provided so that the diameter increases as it moves from the drug discharging part (111) to the drug receiving body part (115).
[0158] The drug receiving main body (115) extends away from the drug connection part (113) and the cover part (3) and may be provided with a constant diameter. That is, the drug receiving main body (115) has the largest diameter and the largest area among the drug receiving parts (11), so that the drug can be effectively stored.
[0159] The drug-closing portion (117) may be provided to extend away from the cover portion (3) in the drug-receiving body portion (115) and to have a decreasing diameter. In addition, the drug-closing portion (117) may be formed by joining the mold insert portion (18). That is, the drug-closing portion (117) may be provided to have a decreasing diameter as it moves away from the drug-receiving body portion (115) as pressure is applied while joining the mold insert portion (18).
[0160] That is, the drug receiving portion (11) can efficiently store drugs by diversifying the diameters of the drug discharge portion (111), drug connection portion (113), drug receiving main body portion (115), and drug closing portion (117), and can enable users to use the drug easily, and can also facilitate the manufacture of the product.
[0161] In addition, the thickness (t1) of the drug connection part (113) may be provided to be greater than the thickness (t2) of the drug receiving body part (115) and the thickness (t3) of the drug finishing part (117). That is, the drug connection part (113) connects the drug receiving body part (115) and the drug discharge part (111), and as a flow path through which the drug is discharged when the user uses the drug, the thickness is provided to be relatively large, thereby improving structural safety.
[0162] Specifically, the thickness (t2) of the drug receiving body (115) is provided to be greater than the thickness (t3) of the drug finishing body (117), and the thickness (t1) of the drug connecting body (113) can be provided to be 2 to 4 times the thickness (t2) of the drug receiving body (115).
[0163] Since the drug receiving body (115) is not a path through which the drug is discharged when the user uses the drug, the thickness is designed to be relatively small in order to store the drug as much as possible, thereby maximizing the storage capacity while ensuring a certain level of structural safety.
[0164] In addition, in the case of the drug closing part (117), the thickness is made relatively smaller than that of the drug receiving body part (115) due to compression during manufacturing, thereby maximizing the storage capacity while ensuring a certain level of structural safety.
[0165] The thickness (t1) of the drug connection part (113) is set to 2 to 4 times the thickness (t2) of the drug receiving body part (115), so that the structural safety can be more efficiently secured when the user uses the drug, and the overall storage capacity and the user's usability can be effectively secured.
[0166] Meanwhile, a drip-type medicine tube (T) according to another embodiment of the present invention may further include a main body finishing part (12). The main body finishing part (12) is connected to the medicine finishing part (117) and the main body support part (13), and may be provided with a diameter smaller than that of the medicine finishing part (117).
[0167] In addition, the main body finishing part (12) can be formed by joining the mold insert part (18). That is, the main body finishing part (12) can be formed by being compressed during the process of joining the mold insert part (18). Accordingly, the manufacturing process of the drip-type chemical tube (T) can be simplified, and the joint area can be minimized to reduce the possibility of chemical leakage. Furthermore, the main body finishing part (12) can also be formed by compressing the end of the main body support part (13) together when joining and compressing the mold insert part (18).
[0168] Meanwhile, the cover part (3) according to another embodiment of the present invention may include a cover main body part (31), a cover protrusion part (33), and a cover removal part (35).
[0169] The cover main body (31) is provided in a plate shape and can be spaced apart from the main body support part (13). That is, the cover main body (31) can be provided in a plate shape so that the user can easily grip it when removing the cover part (3), and the main body support part (13) can also be provided in a plate shape so that the user can easily grip it and remove the cover part (3).
[0170] In addition, the thickness of the cover main body (31) may be provided to be greater than the thickness of the main body support part (13). That is, the main body support part (13) is connected to the drug receiving part (11) where the drug is received, so that a certain level of structural safety can be secured, but the cover main body part (31) occupies most of the area of the cover part (3), so that the user can easily grip it when removing it, and the thickness may be provided to be greater than the main body support part (13) so that the structural safety is increased.
[0171] The cover protrusion (33) may be formed to protrude in a shape corresponding to the drug discharge portion (111) on one side of the cover main body (31) facing the drug discharge portion (111). That is, the cover protrusion (33) may be formed to have the same shape as the drug discharge portion (111) and a larger cross-section than the drug discharge portion (111).
[0172] Accordingly, the user can effectively remove the cover part (3) and, after using the medicine, close the medicine discharge part (111) again through the cover protrusion part (33) to enable temporary storage.
[0173] The cover removal part (35) extends from the cover main body part (31) to both ends of the main body support part (13), and may be provided so that the cross-sectional area decreases as it moves from the cover main body part (31) toward the main body support part (13). That is, the cover removal part (35) is a part that is directly connected to the main body part (1), and the cover main body part (31) is provided with a thickness greater than a certain level to ensure structural safety while allowing the user to easily remove the cover part (3) from the main body part (1).
[0174] The cover protrusion (33) may include a cover protrusion main body (331) and a cover protrusion closing portion (335). The cover protrusion main body (331) may have an inner diameter larger than the outer diameter of the drug discharge portion (111). In addition, the cover protrusion closing portion (335) is provided on one side of the cover protrusion main body (331) facing the drug discharge portion (111), and may extend parallel to the drug discharge portion (111).
[0175] That is, the cover protrusion closing portion (335) can close the opening of the drug discharge portion (111) by being connected to the end of the drug discharge portion (111) from the inner surface of the cover protrusion main body portion (331). Accordingly, the drip-type drug tube (T) according to another embodiment of the present invention has the structural safety maximized, and the drug can be prevented from leaking between the cover portion (3) and the main body portion (1) as much as possible.
[0176] Meanwhile, a drip-type medicine tube (T) according to another embodiment of the present invention may be provided with a material containing 50% ultra-high molecular weight polyethylene (UHMWPE). That is, the main body (1) and the cover part (3) may be provided with a material containing 50% ultra-high molecular weight polyethylene (UHMWPE).
[0177] UHMWPE boasts excellent moisture resistance, abrasion resistance, resistance to various organic solvents, and resistance to strong acids and alkalis, making it a frequent replacement for steel (especially wire). Because it is much lighter than steel and floats, it is widely used in ship cables and fishing lines.
[0178] Steel cables, in particular, are extremely dangerous if they are severed under tension (a fatal blow to a person can result). However, UHMWPE cables are lightweight, so even if they are severed and sent flying, they won't cause serious injury. Furthermore, they are much cheaper and easier to manufacture than carbon fiber.
[0179] That is, the main body (1) and the cover (3) are made of a material containing 50% UHMWPE, so that the evaporation of the medicine inside the medicine tube can be prevented to the greatest extent possible even when stored for a long period of time.
[0180] Fig. 13 is a drawing illustrating a method for manufacturing a drip-type medicine tube according to another embodiment of the present invention. Specifically, Fig. 13(a) is a flowchart of a method for manufacturing a drip-type medicine tube according to another embodiment of the present invention, and Fig. 13(b) is a drawing illustrating a process for joining and cutting a drip-type medicine tube according to another embodiment of the present invention.
[0181] Referring to FIG. 13, a method (S) for manufacturing a drip-type medicine tube according to another embodiment of the present invention may include a placement step (S1), an injection step (S2), a removal step (S3), an injection step (S4), a bonding step (S5), a compression step (S6), and a cutting step (S7).
[0182] That is, manufacturing the above-described drip-type drug tube (T) may include a placement step (S1), an injection step (S2), a removal step (S3), an injection step (S4), and a joining step (S5). The placement step (S1) may include placing a first mold (Y1) for integrally forming the exterior of the main body (1) and the cover part (3) and a second mold (Y2) for forming the internal space (V) of the drug receiving part (11).
[0183] The injection stage (S2) can inject a molding material between the first mold (Y1) and the second mold (Y2). In other words, the injection stage (S2) can be viewed as a type of injection molding that injection molds existing plastic injection products.
[0184] The removal step (S3) can remove the second mold (Y2) from the mold insertion part (18). That is, the removal step (S3) has a structural feature that only requires the second mold (Y2) to be withdrawn from the mold insertion part (18), so that the second mold (Y2) can be easily removed.
[0185] The injection step (S4) can inject the drug into the mold insertion part (18). That is, the injection step (S4) can easily inject the drug due to the simple structural features of the mold insertion part (18).
[0186] The bonding step (S5) can bond the mold insertion part (18). That is, the bonding step (S5) can bond the upper and lower parts of the mold insertion part (18) through heat welding or ultrasonic welding.
[0187] The compression step (S6) compresses the mold insert (18) and the main body support (13) joined in the joining step (S5) to increase the joining force of the mold insert (18), and can form the entire appearance of the drip-type medicine tube (T) in an aesthetically pleasing manner.
[0188] In the cutting step (S7), the main body support part (13) may protrude outward while going through the joining step (S5) and the compression step (S6), and the protruding part may be cut. Accordingly, the overall appearance of the drip-type medicine tube (T) can be formed to be aesthetically pleasing.
[0189] While representative embodiments of the present invention have been described in detail above, those skilled in the art will appreciate that various modifications to the above-described embodiments are possible without departing from the scope of the present invention. Therefore, the scope of the present invention should not be limited to the described embodiments, but should be defined not only by the claims set forth below but also by equivalents thereof.
[0190] [Explanation of symbols]
[0191] T: medicine tube V: inner space
[0192] 1: Main body 3: Cover
[0193] 5: Connection part 7: Fixed part
[0194] S: Manufacturing method
Claims
1. A main body that forms the exterior and contains the medicine; and A cover part formed integrally with the main body and provided to be removed when the drug is used; The above main body part A drug receiving section having an internal space formed to receive the above drug; A main body support part provided with an extension on the outside of the above drug container; An upper insertion portion extending upwardly and inclined away from the cover portion from the drug receiving portion and the main body support portion; and A lower insertion portion facing the upper insertion portion and extending downwardly in a slanted manner away from the drug receiving portion and the main body support portion and away from the cover portion; The inner space is formed by injection molding with the mold inserted between the upper insertion part and the lower insertion part. A drip-type medicine tube characterized in that the medicine is injected into the internal space after the mold is removed, and the upper insertion part and the lower insertion part are joined.
2. In paragraph 1, A drip-type medicine tube, characterized in that the angle (θ) formed by the upper insertion portion and the lower insertion portion is provided to be 10 to 20 degrees.
3. In paragraph 2, A drip-type medicine tube, characterized in that the angle (θ) formed by the upper insertion portion and the lower insertion portion is provided to be 12.5 degrees to 17.5 degrees.
4. In paragraph 3, The above drug receiving section A drug discharge unit formed integrally with the cover unit and through which the drug is discharged when the cover unit is removed; A drug connection part that extends away from the cover part in the drug discharge part and is provided with an increasing diameter; A drug receiving body part extending away from the above drug connecting part and having a constant diameter; and Including a drug-containing main body part, a drug-containing finishing part that extends away from the cover part and is provided with a reduced diameter; The above upper insertion part is formed by passing through the drug finishing part at the first point of the drug receiving body part, The above lower insertion part is formed by passing through the drug finishing part at the first point of the drug receiving body part, A drop-type medicine tube, characterized in that the first point is positioned closer to the medicine end portion than the center of the medicine receiving body portion.
5. In paragraph 4, A drop-type medicine tube, characterized in that the distance (E1) from the medicine finishing part to the first point is provided to be between 0.7 and 0.9 of the distance (E2) from the medicine finishing part to the center of the medicine receiving body part.
6. In paragraph 4, A drop-type medicine tube, characterized in that the distance (E1) from the medicine finishing part to the first point is between 0.75 and 0.85 of the distance (E2) from the medicine finishing part to the center of the medicine receiving body part.
7. In paragraph 6, A drip-type medicine tube characterized in that the thickness (t1) of the medicine connection part is greater than the thickness (t2) of the medicine receiving body part and the thickness (t3) of the medicine finishing part.
8. In paragraph 7, The thickness (t2) of the above drug-receiving body and the thickness (t3) of the above drug-finishing part are provided to be the same. A drip-type medicine tube, characterized in that the thickness (t1) of the medicine connection part is 2 to 4 times the thickness (t2) of the medicine receiving body part.
9. In paragraph 8, The above main body part A drip-type medicine tube, characterized in that it further includes an insertion support part including a first insertion support part protruding upward from the end of the upper insertion part and a second insertion support part protruding downward from the end of the lower insertion part.
10. In paragraph 9, The above cover part A cover body part having a plate shape and spaced apart from the main body support part; A cover protrusion formed on one side of the cover main body facing the drug discharge portion in a shape corresponding to the drug discharge portion; and A cover removal part extending from the cover main body to both ends of the main body support part and provided so that the cross-sectional area decreases as it moves from the cover main body to the main body support part; The above cover protrusion A cover protrusion body portion having an inner diameter larger than the outer diameter of the above-mentioned drug discharge portion; and A drip-type medicine tube characterized by including a cover protrusion central portion formed by being recessed in a direction away from the medicine discharge portion on one surface of the cover protrusion main body portion facing the medicine discharge portion.
11. In paragraph 10, A drip-type medicine tube characterized in that the outer diameter (D1) of the above-mentioned cover protrusion body part is provided to be 1.1 to 1.3 times the outer diameter (D2) of the above-mentioned medicine discharge part.
12. In the manufacturing method of the drip-type medicine tube of paragraph 1, A placement step of placing a first mold for integrally forming the exterior of the main body and the cover and a second mold for forming the internal space of the drug receiving portion; An injection step of injecting a molding material between the first mold and the second mold; A removal step of removing the second mold between the upper insertion part and the lower insertion part; An injection step of injecting the drug between the upper insertion part and the lower insertion part; and A method for manufacturing a drip-type medicine tube, comprising a joining step of joining the upper insertion part and the lower insertion part.
13. A main body that forms the exterior and contains the medicine; and A cover part formed integrally with the main body and provided to be removed when the drug is used; The above main body part A drug receiving section having an internal space formed to receive the above drug; A main body support part extended to the outside of the above drug container; and It includes a mold insertion part provided at the end of the above drug receiving part and into which a mold is inserted; The internal space is formed by injection molding with the mold inserted into the above mold insertion section. A drip-type medicine tube characterized in that the medicine is injected into the internal space after the mold is removed and the mold insertion part is joined.
14. In paragraph 13, The above drug receiving section A drug discharge unit formed integrally with the cover unit and through which the drug is discharged when the cover unit is removed; A drug connection part that extends away from the cover part in the drug discharge part and is provided with an increasing diameter; A drug receiving body part extending away from the above drug connecting part and having a constant diameter; and Including a drug-containing main body part, a drug-containing finishing part that extends away from the cover part and is provided with a reduced diameter; A drop-type drug tube characterized in that the above drug finishing part is formed by joining the above mold insertion part.
15. In paragraph 14, It further includes a main body finishing part that is connected to the above-mentioned drug finishing part and the above-mentioned main body support part and has a diameter smaller than the above-mentioned drug finishing part; A drop-type medicine tube characterized in that the main body finishing part is formed by joining the mold insertion part.
Citation Information
Patent Citations
Liquid medicine container
JP2004083115A
Container and production method thereof
JP2018079262A
Containers for fluid substances
JP3171479U
Drug Solution Filling Plastic Ampoule and Process forProducing the Same
KR1020060003896A
Co-extrusion blow molding apparatus and method, and sealed empty devices
US20100094245A1
